Literature DB >> 19252830

Competitive antigen panning for selection of HIV-1 neutralizing human monoclonal antibodies specific for gp41.

Mei-Yun Zhang1, Dimiter S Dimitrov.   

Abstract

HIV envelope glycoprotein (Env) is composed of two non-covalently associated subunits: gp120 and gp41. Panning of phage-displayed antibody libraries against gp140 (covalently linked gp120 and the extracellular portion of gp41) has resulted mostly in selection of anti-gp120 antibodies. Native gp41 in the absence of gp120 is unstable. The use of gp41 fragments as antigens has resulted in selection of antibodies with only relatively modest neutralizing activity. To enhance selection of antibodies specific for gp41 in the context of the whole Env we developed a methodology termed competitive antigen panning (CAP). Using CAP, we identified a panel of gp41-specific human monoclonal antibodies from an HIV-1 immune library derived from long-term nonprogressors. These antibodies recognize conformational epitopes in gp41 and exhibited, to various extents, neutralization activity in assays based on spreading infection in peripheral blood mononuclear cells. The CAP methodology is generally applicable for selection of antibodies specific for any epitope that is not a dominant epitope in the antigen. It is superior to a traditional pre-depletion method in avoiding potential loss of target-specific antibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252830      PMCID: PMC3399416          DOI: 10.1007/978-1-59745-554-1_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Overview of antibody phage-display technology and its applications.

Authors:  Hennie R Hoogenboom
Journal:  Methods Mol Biol       Date:  2002

Review 2.  Antibody phage display technology and its applications.

Authors:  H R Hoogenboom; A P de Bruïne; S E Hufton; R M Hoet; J W Arends; R C Roovers
Journal:  Immunotechnology       Date:  1998-06

Review 3.  Designing and optimizing library selection strategies for generating high-affinity antibodies.

Authors:  H R Hoogenboom
Journal:  Trends Biotechnol       Date:  1997-02       Impact factor: 19.536

Review 4.  Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency.

Authors:  Mei-Yun Zhang; Dimiter S Dimitrov
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

5.  Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.

Authors:  Mei-Yun Zhang; Vidita Choudhry; Igor A Sidorov; Vladimir Tenev; Bang K Vu; Anil Choudhary; Hong Lu; Gabriela M Stiegler; Hermann W D Katinger; Shibo Jiang; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Immunol Methods       Date:  2006-10-16       Impact factor: 2.303

6.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

  6 in total
  1 in total

1.  Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.

Authors:  Mei-Yun Zhang; Tingting Yuan; Jingjing Li; Andrew Rosa Borges; Jennifer D Watkins; Javier Guenaga; Zheng Yang; Yanping Wang; Richard Wilson; Yuxing Li; Victoria R Polonis; Seth H Pincus; Ruth M Ruprecht; Dimiter S Dimitrov
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.